Skip to main content
. 2004 Jan;48(1):116–123. doi: 10.1128/AAC.48.1.116-123.2004

FIG. 2.

FIG. 2.

Median steady-state plasma APV concentration-time profiles for the 908 1,395-mg BID (♦; n = 22), 908 1,860-mg BID (▪; n = 31), and APV 1,200-mg (▴; n = 53) groups at the end of treatment period 1 (day 28).